Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Drug-induced pigmentation may be diffuse but localized to one mucosal region, or it can be multifocal and involve multiple surfaces ( Fig
For higher or adjustable dosing options, please refer to our standard GLP-1 program
In rare cases, a serious allergic reaction may occur
Component-Level Trial Findings CJC-1295 (without DAC, modified GRF 1-29) Phase 1 and Phase 2 work described: Dose-dependent GH elevation (2-10x baseline at studied doses, PMID 16352683) IGF-1 elevation of 1.5-3x baseline at 1-2 weeks Mild facial flushing post-injection in some participants No serious adverse events at studied doses CJC-1295 with DAC The DAC-modified version covalently binds to albumin, extending half-life to 5-8 days (PMID 16352683)
US$ 23.60
US$ 29.37
US$ 28.15
US$ 28.59
US$ 26.42
US$ 25.06
US$ 21.02
US$ 21.19
US$ 28.10
US$ 21.28
